PerpEquities

Equity

AstraZeneca PLC (AZN) perpetual futures

AZN perpetual futures on 2 crypto exchanges – live perp price vs the stock, funding rate, open interest and where to trade AZNUSDT.

AstraZeneca PLC is a global biopharmaceutical company that discovers, develops, manufactures and commercializes prescription medicines for cardiovascular, renal, metabolic, oncological, COVID-19 and rare diseases.

$170.37+2.4%NYSE closed
Open in terminal

Price chart

 

Use the left and right arrow keys to inspect points on the chart.

Collecting venue price data...
venue perp mark · BingX (AZN-USDT)
Auto: highest-volume live perp venueOpen in TradingView

Trading data

Perpetual market activity

2/2 live markets
Venues
2
Live markets
2/2
24h volume
$101.5KCoverage: 1/2 marketsExchange-reported volume: $1.3M
Open interest
$1.8M
Best liquidity
$54.1K
BingX
Tightest spread
+30.5 bps
MEXC
Highest volume
$101.5K
MEXC
Settlement mix
USDT · 2/2
Perp/spot vol.
0.00x
Spot volume $472.5M
OI / float
0.00%
Float $262.9B
Spot performance
1D+2.45%
5D+3.35%
1M+5.66%
6M-10.26%
YTD-1.67%
1Y+2.57%

Venue matrix

2 markets

Some venue links are sponsored. We may receive a commission, and eligible users may occasionally receive trading-fee discounts, at no additional cost to you.

Trade
MEXCTradeAZN/USDTTrading$170.45-15.0% APR
-0.014% every 8h
+30.5 bps$12.3K$101.5K$1.8MUSDT20x
BingXTradeAZN-USDTTrading$170.37-10.5% APR
-0.00960% every 8h
+99.7 bps$54.1K$1.2M⚠$1.7KUSDT-

Unverified volume: implausibly high against open interest, a typical sign of wash trading. These venues are listed last.

Tradability

Execution quality

Entry cost and depth per venue at $1k–$100k

Thin liquidity · 1 of 2 venues absorb $10k · Typical cost: +112.3 bps

Cheapest execution: BingX · +112.3 bps

Too thin: MEXC

Taker execution estimate incl. approx. fees - maker fills are not guaranteed.

Best venues for this underlying

Best liquidity

AZN

Tightest spread

AZN

Highest volume

AZN

Funding history

Stored venue snapshots by market

Company data

Company fundamentals

Updated 2h ago
Market cap
$267.6B
Updated 2h ago
Revenue
$61.4B
Trailing 12 months
Revenue growth
+7%
Next fiscal year
Profit margin
+17.0%
P/E
25.4
Peer P/E 25.7
Free cash flow
$8.7B
Trailing 12 months
More metrics
Net income
$10.4B
Trailing 12 months
P/S
4.4
Peer P/E
25.7
Similar listed perps
Revenue estimate
$62.9B
Next fiscal year
Earnings
2026-10-30
Revenue est. $16B · Updated 2h ago
Dividend
$1.06
2026-08-07

Fundamental detail

Annual + quarterly
Latest revenue$58.7B
Net margin+17.5%
Free cash flow$8.7B
Net debt$24B
2020$26.6B
2021$37.4B
2022$44.4B
2023$45.8B
2024$54.1B
2025$58.7B
PeriodRevenueGrowthNet incomeFCF
2020$26.6B+9%$3.2B$2.2B
2021$37.4B+41%$112M$3.8B
2022$44.4B+19%$3.3B$7.2B
2023$45.8B+3%$6B$6.6B
2024$54.1B+18%$7B$7.3B
2025$58.7B+9%$10.3B$8.7B
PeriodGross marginOperating marginNet marginROEROA
2020+80.1%+19.4%+12.0%+20.5%+4.8%
2021+66.8%+2.8%+0.3%+0.3%+0.1%
2022+72.1%+8.5%+7.4%+8.9%+3.4%
2023+82.0%+17.9%+13.0%+15.2%+5.9%
2024+81.1%+18.5%+13.0%+17.2%+6.8%
2025+81.9%+23.4%+17.5%+21.1%+9.0%
PeriodCashDebtNet debtCurrent ratio
2020$7.8B$20.4B$12.5B0.96
2021$6.3B$30.7B$24.4B1.16
2022$6.2B$29.1B$23B0.86
2023$5.8B$28.6B$22.8B0.82
2024$5.5B$30.1B$24.6B0.93
2025$5.7B$29.7B$24B0.94
PeriodMarket capEnterprise valueP/SP/E
2020$132.5B$145.1B5.041.4
2021$164.3B$188.6B4.41,448.1
2022$210.9B$233.8B4.864.3
2023$207.4B$230.2B4.534.9
2024$201.5B$226.1B3.728.6
2025$272B$296B4.626.6
Q3 2024$13.6B
Q4 2024$14.9B
Q1 2025$13.6B
Q2 2025$14.5B
Q3 2025$15.2B
Q4 2025$15.5B
Q1 2026$15.3B
Q2 2026$15.4B
PeriodRevenueGrowthNet incomeFCF
Q3 2024$13.6B+18%$1.4B$2B
Q4 2024$14.9B+24%$1.5B$2B
Q1 2025$13.6B+7%$2.9B$2.7B
Q2 2025$14.5B+12%$2.5B$1.5B
Q3 2025$15.2B+12%$2.5B$3.4B
Q4 2025$15.5B+4%$2.3B$1.4B
Q1 2026$15.3B+13%$3.1B$1.8B
Q2 2026$15.4B+6%$2.5B$2.1B
PeriodGross marginOperating marginNet marginROEROA
Q3 2024+77.3%+15.5%+10.5%+3.5%+1.4%
Q4 2024+81.7%+13.7%+10.1%+3.7%+1.4%
Q1 2025+83.5%+27.0%+21.5%+7.1%+2.7%
Q2 2025+82.9%+24.3%+16.9%+5.5%+2.2%
Q3 2025+81.6%+23.6%+16.7%+5.5%+2.2%
Q4 2025+79.9%+19.2%+15.0%+4.8%+2.0%
Q1 2026+82.5%+27.8%+20.1%+6.5%+2.7%
Q2 2026+83.6%+20.6%+16.3%+5.0%+2.2%
PeriodCashDebtNet debtCurrent ratio
Q3 2024$4.8B$31.6B$26.8B0.93
Q4 2024$5.5B$30.1B$24.6B0.93
Q1 2025$5.2B$31.7B$26.5B0.90
Q2 2025$7.1B$32.8B$25.8B0.86
Q3 2025$8.1B$32.7B$24.5B0.88
Q4 2025$5.7B$29.7B$24B0.94
Q1 2026$7.6B$33.9B$26.4B0.91
Q2 2026$4.9B$32.2B$27.3B0.89
PeriodMarket capEnterprise valueP/SP/E
Q3 2024$242.1B$268.9B17.942.3
Q4 2024$201.5B$226.1B13.533.5
Q1 2025$228.4B$254.9B16.819.6
Q2 2025$216.6B$242.4B15.022.1
Q3 2025$233.4B$257.9B15.423.1
Q4 2025$272B$296B17.529.1
Q1 2026$305.5B$331.9B20.024.8
Q2 2026$294.1B$321.4B19.129.6

Refreshed 2h ago

Charts: revenue, profit, cash flow & valuation
Revenue$15.4BQ2 2026
$3.9B$7.8B$11.6B$15.5BQ3 2023: $11.5BQ4 2023: $12BQ1 2024: $12.7BQ2 2024: $12.9BQ3 2024: $13.6BQ4 2024: $14.9BQ1 2025: $13.6BQ2 2025: $14.5BQ3 2025: $15.2BQ4 2025: $15.5BQ1 2026: $15.3BQ2 2026: $15.4BQ3 2023Q2 2026
Net income$2.5BQ2 2026
$770M$1.5B$2.3B$3.1BQ3 2023: $1.4BQ4 2023: $960MQ1 2024: $2.2BQ2 2024: $1.9BQ3 2024: $1.4BQ4 2024: $1.5BQ1 2025: $2.9BQ2 2025: $2.5BQ3 2025: $2.5BQ4 2025: $2.3BQ1 2026: $3.1BQ2 2026: $2.5BQ3 2023Q2 2026
EBITDA$5.2BQ2 2026
$1.4B$2.8B$4.3B$5.7BQ3 2023: $3.3BQ4 2023: $2.7BQ1 2024: $4.5BQ2 2024: $4.1BQ3 2024: $4.1BQ4 2024: $2.8BQ1 2025: $5BQ2 2025: $5BQ3 2025: $5.2BQ4 2025: $4.6BQ1 2026: $5.7BQ2 2026: $5.2BQ3 2023Q2 2026
Free cash flow$2.1BQ2 2026
$852M$1.7B$2.6B$3.4BQ3 2023: $2.2BQ4 2023: $1.4BQ1 2024: $881MQ2 2024: $2.4BQ3 2024: $2BQ4 2024: $2BQ1 2025: $2.7BQ2 2025: $1.5BQ3 2025: $3.4BQ4 2025: $1.4BQ1 2026: $1.8BQ2 2026: $2.1BQ3 2023Q2 2026
EPS$1.59Q2 2026
$0.49$0.99$1.48$1.97Q3 2023: $0.88Q4 2023: $0.61Q1 2024: $1.4Q2 2024: $0.62Q3 2024: $0.91Q4 2024: $0.96Q1 2025: $1.87Q2 2025: $1.57Q3 2025: $1.62Q4 2025: $1.48Q1 2026: $1.97Q2 2026: $1.59Q3 2023Q2 2026
Cash / Debt$4.9BQ2 2026
$8.6B$17.3B$25.9B$34.6BQ3 2023 · Cash: $4.9BQ3 2023 · Debt: $28.6BQ4 2023 · Cash: $5.8BQ4 2023 · Debt: $28.6BQ1 2024 · Cash: $7.8BQ1 2024 · Debt: $34.6BQ2 2024 · Cash: $6.9BQ2 2024 · Debt: $33.5BQ3 2024 · Cash: $4.8BQ3 2024 · Debt: $31.6BQ4 2024 · Cash: $5.5BQ4 2024 · Debt: $30.1BQ1 2025 · Cash: $5.2BQ1 2025 · Debt: $31.7BQ2 2025 · Cash: $7.1BQ2 2025 · Debt: $32.8BQ3 2025 · Cash: $8.1BQ3 2025 · Debt: $32.7BQ4 2025 · Cash: $5.7BQ4 2025 · Debt: $29.7BQ1 2026 · Cash: $7.6BQ1 2026 · Debt: $33.9BQ2 2026 · Cash: $4.9BQ2 2026 · Debt: $32.2BQ3 2023Q2 2026
CashDebt
Profitability+83.6%Q2 2026
+20.9%+41.8%+62.7%+83.6%Q3 2023 · Gross margin: +81.8%Q4 2023 · Gross margin: +80.8%Q1 2024 · Gross margin: +82.5%Q2 2024 · Gross margin: +83.1%Q3 2024 · Gross margin: +77.3%Q4 2024 · Gross margin: +81.7%Q1 2025 · Gross margin: +83.5%Q2 2025 · Gross margin: +82.9%Q3 2025 · Gross margin: +81.6%Q4 2025 · Gross margin: +79.9%Q1 2026 · Gross margin: +82.5%Q2 2026 · Gross margin: +83.6%Q3 2023 · Operating margin: +17.0%Q4 2023 · Operating margin: +10.3%Q1 2024 · Operating margin: +24.6%Q2 2024 · Operating margin: +21.2%Q3 2024 · Operating margin: +15.5%Q4 2024 · Operating margin: +13.7%Q1 2025 · Operating margin: +27.0%Q2 2025 · Operating margin: +24.3%Q3 2025 · Operating margin: +23.6%Q4 2025 · Operating margin: +19.2%Q1 2026 · Operating margin: +27.8%Q2 2026 · Operating margin: +20.6%Q3 2023 · Net margin: +12.0%Q4 2023 · Net margin: +8.0%Q1 2024 · Net margin: +17.2%Q2 2024 · Net margin: +14.9%Q3 2024 · Net margin: +10.5%Q4 2024 · Net margin: +10.1%Q1 2025 · Net margin: +21.5%Q2 2025 · Net margin: +16.9%Q3 2025 · Net margin: +16.7%Q4 2025 · Net margin: +15.0%Q1 2026 · Net margin: +20.1%Q2 2026 · Net margin: +16.3%Q3 2023Q2 2026
Gross marginOperating marginNet margin
Revenue growth+6.4%Q2 2026
+6.0%+11.9%+17.9%+23.8%Q3 2024: +18.0%Q4 2024: +23.8%Q1 2025: +7.2%Q2 2025: +11.7%Q3 2025: +12.0%Q4 2025: +4.1%Q1 2026: +12.5%Q2 2026: +6.4%Q3 2023Q2 2026
Shares outstanding1.6BQ2 2026
390.5M781M1.2B1.6BQ3 2023: 1.6BQ4 2023: 1.6BQ1 2024: 1.6BQ2 2024: 1.6BQ3 2024: 1.6BQ4 2024: 1.6BQ1 2025: 1.6BQ2 2025: 1.6BQ3 2025: 1.6BQ4 2025: 1.6BQ1 2026: 1.6BQ2 2026: 1.6BQ3 2023Q2 2026
Valuation29.6Q2 2026
15.931.847.663.5Q3 2023 · P/E: 37.9Q4 2023 · P/E: 54.4Q1 2024 · P/E: 24.1Q2 2024 · P/E: 63.5Q3 2024 · P/E: 42.3Q4 2024 · P/E: 33.5Q1 2025 · P/E: 19.6Q2 2025 · P/E: 22.1Q3 2025 · P/E: 23.1Q4 2025 · P/E: 29.1Q1 2026 · P/E: 24.8Q2 2026 · P/E: 29.6Q3 2023 · P/S: 18.2Q4 2023 · P/S: 17.1Q1 2024 · P/S: 16.6Q2 2024 · P/S: 18.9Q3 2024 · P/S: 17.9Q4 2024 · P/S: 13.5Q1 2025 · P/S: 16.8Q2 2025 · P/S: 15.0Q3 2025 · P/S: 15.4Q4 2025 · P/S: 17.5Q1 2026 · P/S: 20.0Q2 2026 · P/S: 19.1Q3 2023Q2 2026
P/EP/S
Revenue$58.7B2025
$14.7B$29.4B$44.1B$58.7B2018: $22.1B2019: $24.4B2020: $26.6B2021: $37.4B2022: $44.4B2023: $45.8B2024: $54.1B2025: $58.7B20182025
Net income$10.3B2025
$2.6B$5.1B$7.7B$10.3B2018: $2.2B2019: $1.3B2020: $3.2B2021: $112M2022: $3.3B2023: $6B2024: $7B2025: $10.3B20182025
EBITDA$19.8B2025
$5B$9.9B$14.9B$19.8B2018: $7.1B2019: $6.7B2020: $8.1B2021: $5.1B2022: $9.1B2023: $13.4B2024: $15.4B2025: $19.8B20182025
Free cash flow$8.7B2025
$2.2B$4.3B$6.5B$8.7B2018: $1.2B2019: $509M2020: $2.2B2021: $3.8B2022: $7.2B2023: $6.6B2024: $7.3B2025: $8.7B20182025
EPS$6.542025
$1.64$3.27$4.91$6.542018: $1.72019: $1.032020: $2.442021: $0.082022: $2.112023: $3.812024: $4.52025: $6.5420182025
Cash / Debt$5.7B2025
$7.7B$15.3B$23B$30.7B2018 · Cash: $4.8B2018 · Debt: $19.1B2019 · Cash: $5.4B2019 · Debt: $18.2B2020 · Cash: $7.8B2020 · Debt: $20.4B2021 · Cash: $6.3B2021 · Debt: $30.7B2022 · Cash: $6.2B2022 · Debt: $29.1B2023 · Cash: $5.8B2023 · Debt: $28.6B2024 · Cash: $5.5B2024 · Debt: $30.1B2025 · Cash: $5.7B2025 · Debt: $29.7B20182025
CashDebt
Profitability+81.9%2025
+20.5%+41.0%+61.5%+82.0%2018 · Gross margin: +77.7%2019 · Gross margin: +79.8%2020 · Gross margin: +80.1%2021 · Gross margin: +66.8%2022 · Gross margin: +72.1%2023 · Gross margin: +82.0%2024 · Gross margin: +81.1%2025 · Gross margin: +81.9%2018 · Operating margin: +15.3%2019 · Operating margin: +12.0%2020 · Operating margin: +19.4%2021 · Operating margin: +2.8%2022 · Operating margin: +8.5%2023 · Operating margin: +17.9%2024 · Operating margin: +18.5%2025 · Operating margin: +23.4%2018 · Net margin: +9.8%2019 · Net margin: +5.5%2020 · Net margin: +12.0%2021 · Net margin: +0.3%2022 · Net margin: +7.4%2023 · Net margin: +13.0%2024 · Net margin: +13.0%2025 · Net margin: +17.5%20182025
Gross marginOperating marginNet margin
Revenue growth+8.6%2025
+10.1%+20.3%+30.4%+40.6%2019: +10.4%2020: +9.2%2021: +40.6%2022: +18.5%2023: +3.3%2024: +18.0%2025: +8.6%20182025
Shares outstanding1.6B2025
390.8M781.5M1.2B1.6B2018: 1.3B2019: 1.3B2020: 1.3B2021: 1.4B2022: 1.6B2023: 1.6B2024: 1.6B2025: 1.6B20182025
Valuation26.62025
362.0724.11,086.11,448.12018 · P/E: 44.72019 · P/E: 98.12020 · P/E: 41.42021 · P/E: 1,448.12022 · P/E: 64.32023 · P/E: 34.92024 · P/E: 28.62025 · P/E: 26.62018 · P/S: 4.42019 · P/S: 5.42020 · P/S: 5.02021 · P/S: 4.42022 · P/S: 4.82023 · P/S: 4.52024 · P/S: 3.72025 · P/S: 4.620182025
P/EP/S

Next catalyst

Catalysts

Earnings
2026-10-30
Revenue est. $16B · Updated 2h ago
Dividend
$1.06
2026-08-07

No unusual perp activity right now.

Research data

Analysts, filings and peer context

Estimates

6
DateEPS estimateRevenue estimateGrowthAnalysts
FY 202610.25$62.9B+7%7
FY 202711.41$67.1B+14%8
FY 202812.73$71.2B+21%12
FY 202914.52$76.3B+30%9
FY 203016.18$81.3B+38%5
Q3 20262.59$16B+5%2

Company events

6
2026-10-30Earnings · Before market openActual - / Estimate 2.59-
2026-08-07Dividend$1.06-
2026-07-27EarningsActual 2.63 / Estimate 2.5Beat
2026-04-29EarningsActual 2.58 / Estimate 2.57Beat
2026-02-20Dividend$2.17-
2026-02-10EarningsActual 2.12 / Estimate 2.09Beat

Peer comparison

Similar listed perps

Analyst track record

How the analysts covering AZN have done: ratings, price-target accuracy and the measured reaction after their calls.

12 months3 years
Ratings102462
Analysts1734
Buy / hold / sell83 / 6 / 13341 / 80 / 41
Upgrades / downgrades / initiations2 / 0 / 15 / 6 / 4
Price targets hit / missed19 / 78 (20%)133 / 303 (31%)
Avg. return after a rating (TipRanks)+65.2%+36.2%
Best / worst call+7,710.6% / -37.1%+9,813.5% / -37.1%

After buy calls on this stock: median 21-day move +1.2% vs S&P 500 -1.1% (n = 363)

Most accurate on this stock

Share of an analyst's price targets on this stock that the price reached within 12 months (our measurement over the last 3 years, at least 8 targets). It describes past calls, not the odds of the current one.

  1. Matthew WestonUBS100% hit rate on this stock · 31 targets measuredBuytarget $236Apr 30, 2026
  2. Luisa HectorBerenberg Bank70% hit rate on this stock · 20 targets measuredBuytarget $228Mar 16, 2026
  3. Rajan SharmaGoldman Sachs48% hit rate on this stock · 25 targets measuredBuytarget $223Apr 21, 2026

Latest ratings

DateAnalystCallTarget
May 21, 2026Sachin JainBank of America SecuritiesBuyReiterated$222
May 21, 2026Emmanuel PapadakisDeutsche BankSellMaintained$154
May 14, 2026Richard VosserJ.P. MorganBuyMaintained$215
May 13, 2026Michael LeuchtenJefferiesBuyReiterated$242
May 4, 2026Justin SmithBernsteinBuyMaintained$250
Consensus over the last 12 months buy hold sell avg. target month-end close
Monthly buy, hold and sell shares of analyst ratings with the average price target and the month-end close$160$170$180$190$200$210$220Nov 25 · Buy 14 · Hold 3 · Sell 1Nov 25Dec 25 · Buy 16 · Hold 3 · Sell 1Jan 26 · Buy 16 · Hold 2 · Sell 1Jan 26Feb 26 · Buy 14 · Hold 2 · Sell 1Mar 26 · Buy 15 · Hold 2 · Sell 1Mar 26Apr 26 · Buy 15 · Hold 1 · Sell 1May 26 · Buy 15 · Hold 1 · Sell 1May 26Jun 26 · Buy 14 · Hold 1 · Sell 1Jul 26 · Buy 13 · Hold 1 · Sell 1Jul 26Aug 26 · Buy 13 · Hold 1 · Sell 1Sep 26 · Buy 11 · Hold 1 · Sell 1Sep 26Oct 26 · Buy 10 · Hold 1 · Sell 1Nov 25 · avg. target $192Dec 25 · avg. target $194Jan 26 · avg. target $203Feb 26 · avg. target $206Mar 26 · avg. target $214Apr 26 · avg. target $214May 26 · avg. target $212Jun 26 · avg. target $216Jul 26 · avg. target $216Aug 26 · avg. target $216Sep 26 · avg. target $214Oct 26 · avg. target $213Nov 25 · month-end close $184Dec 25 · month-end close $176Jan 26 · month-end close $187Feb 26 · month-end close $208Mar 26 · month-end close $197Apr 26 · month-end close $187May 26 · month-end close $186Jun 26 · month-end close $190Jul 26 · month-end close $170Aug 26 · month-end close $162Sep 26 · month-end close $161Oct 26 · month-end close $165

Share of analysts per call each month (latest call per analyst within 180 days). Targets and closes in USD.

TipRanks data via FMP · computed Oct 23, 2026 · 102 ratings

Frequently asked questions

Where can I trade AZN perpetual futures?

AstraZeneca PLC (AZN) perpetual futures trade on 2 crypto venues, including BingX, MEXC. PerpEquities compares them by live price, funding rate, open interest and liquidity.

Can I trade AZN around the clock?

Yes. Unlike the underlying stock, AZN perpetuals trade 24/7 — including weekends and outside regular market hours.

What is the funding rate on AZN perpetuals?

Right now the AZN perp funding rate is -12.8% annualized (venue median), ranging from -15.0% to -10.5% across 2 venues. A positive rate means longs pay shorts. PerpEquities shows the live rate and its history for every venue.

How does the AZN perp price compare to the AstraZeneca PLC stock?

The venue-median AZN perp mark is $170.4 versus a reference stock price of $170.4, a basis of 0.0%. Perps follow the stock through an index price; the gap widens when funding or liquidity diverge between venues.

What is a AZN perpetual future?

A AZN perpetual is a derivative that tracks the price of AstraZeneca PLC with no expiry date. It lets you take long or short exposure to AstraZeneca PLC on crypto venues, around the clock.

What is AZNUSDT perpetual?

AZNUSDT is the symbol most crypto exchanges use for the AstraZeneca PLC perpetual settled in USDT (Tether). It tracks the AZN share price through an index, trades 24/7 with leverage and never expires.

Embed this asset

AZN perpetuals · perpequities.comAZN perpetuals · perpequities.com
<a href="https://perpequities.com/stocks/azn-perp"><img src="https://perpequities.com/badge/azn-perp.svg" width="240" height="64" alt="AZN perpetuals · perpequities.com" loading="lazy"></a>

Next step

Stay on top of AZN perps

Signals with a track record

Analysts who hit 70%+ of their targets on the perps we track, congress buys over $500k, 13F positions over $5M, funding spreads that have paid for days. Every post shows the evidence. Free, no sign-up.

Join on Telegram

Weekly digest by email

The listings, funding and moves that matter for AZN — one email every Sunday.

Watchlist and alerts

Price and funding alerts for AZN, via push or Telegram.

Set an alert

Follow the live feed

Daily movers, new listings and funding extremes as they happen.

Follow on X